Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.
Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Keelung & Chang Gung University, Taoyuan, Taiwan.
J Plast Reconstr Aesthet Surg. 2024 Dec;99:535-542. doi: 10.1016/j.bjps.2024.10.015. Epub 2024 Oct 11.
Traumatic optic neuropathy (TON) is a rare complication of facial trauma that results in vision loss. Clinical diagnosis of TON is based on a history of head trauma and an ophthalmic examination; however, the risk factors for TON and the ideal treatment strategy remain undetermined. This study aimed to identify predictive risk factors for TON and evaluate the effectiveness of current treatments with respect to visual outcomes in patients with TON.
This study retrospectively enrolled patients with periorbital facial bone fracture between 2008 and 2019. Initial facial bone computed tomography, ophthalmic exam results, initial Glasgow Coma Scale, and Injury Severity Score were recorded. This study classified patients into 4 intervention groups (i.e., medication, surgery, combination therapy, and observation) to compare the outcome of visual acuity.
This study enrolled 1168 patients with facial bone fractures, 93 (7.96%) of whom were diagnosed as having TON. Independent risk factors for TON included optic canal fracture, medial orbital wall fracture, retrobulbar hematoma, and head Abbreviated Injury Scale ≥4. Patients with TON who initially presented with no light perception tended to have poor final visual acuity (VA) outcomes. The results indicated no significant difference in VA improvement among patients receiving observation, megadose corticosteroid therapy, surgical decompression, or combined steroid therapy and decompression.
Clinicians can achieve early prediction of TON in patients with an initial unconscious state and the identified risk factors. The results indicated that the conservative observation yielded noninferior VA outcomes in patients with TON compared with those receiving medication or surgical treatment.
创伤性视神经病变(TON)是一种罕见的面部创伤并发症,可导致视力丧失。TON 的临床诊断基于头部创伤史和眼科检查;然而,TON 的危险因素和理想的治疗策略仍未确定。本研究旨在确定 TON 的预测性危险因素,并评估目前治疗方法对视神经病变患者视力结果的有效性。
本研究回顾性纳入 2008 年至 2019 年间眶周面部骨骨折患者。记录初始面部骨计算机断层扫描、眼科检查结果、初始格拉斯哥昏迷量表和损伤严重程度评分。本研究将患者分为 4 个干预组(即药物治疗、手术治疗、联合治疗和观察),以比较视力结果。
本研究纳入了 1168 例面部骨折患者,其中 93 例(7.96%)被诊断为 TON。TON 的独立危险因素包括视神经管骨折、内侧眶壁骨折、球后血肿和头部损伤严重程度评分≥4。TON 患者初始无光感者往往最终视力(VA)结果较差。结果表明,接受观察、大剂量皮质类固醇治疗、手术减压或联合类固醇治疗和减压的患者在 VA 改善方面无显著差异。
临床医生可以在患者初始无意识状态和确定的危险因素的情况下实现对 TON 的早期预测。结果表明,与接受药物或手术治疗的患者相比,保守观察在 TON 患者中产生了非劣效的 VA 结果。